Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENT CLOT: Aspirin vs LMWH in Orthopaedic Trauma
NCT02984384Phase 3Completed
- Sponsor
- Major Extremity Trauma Research Consortium
- Start
- Apr 2017
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
Phase 3, randomised, single-blind trial of aspirin in venous thromboembolism (VTE) (2 arms), sponsored by Major Extremity Trauma Research Consortium. Primary endpoint: Number of Participants With All-cause Mortality at 90 days. Started Apr 2017; status: completed.
02
Drugs
aspirin
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT02984384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02984384.